FibroGen, Inc.
Pharmaceutical formulations of a HIF hydroxylase inhibitor
Last updated:
Abstract:
The present disclosure relates to pharmaceutical formulations of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid and methods of use thereof.
Status:
Grant
Type:
Utility
Filling date:
13 Jul 2018
Issue date:
8 Sep 2020